Tigatuzumab Biosimilar - Research Grade

Human

TNFRSF10Bï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

O14763

Blue ice

Death receptor 5 (TNFRSF10B, DR5) triggers apoptosis upon ligation and is a long-standing target in cancer cell-death research. This is a non-therapeutic, unconjugated analog of tigatuzumab, a recombinant anti-DR5 monoclonal antibody for research use only. Manufactured to in vivo standards with low endotoxin, it is available in scalable milligram to gram quantities for high-throughput laboratories. The antibody is useful for apoptosis-induction functional assays, in vitro tumor-cell killing screens, and in vivo tumor models exploring death-receptor signaling. Consistent quality across lots makes it a practical choice for laboratories running sustained study programs. Uniform, reproducible material supports robust experimental design at research scale.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks